Mangalam Drugs & Organics Announcements
Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/01/2026 ,inter alia, to...
07 Jan, 2026 | 05:07pm • Source: BSE
Clarification for the query raised by Surveillance Department of BSE Limited dated 5th January,2026 regarding Movement in price of the Company.
07 Jan, 2026 | 12:04pm • Source: BSE
The Exchange has sought clarification from Mangalam Drugs & Organics Ltd on January 5, 2026 with reference to significant movement in price, in order to...
05 Jan, 2026 | 07:00pm • Source: BSE
Intimation of closure of Trading Window from January 1, 2026 till the expiry of Forty-eight (48) hours after the declaration of Un- Audited Financial Results...
01 Jan, 2026 | 04:53pm • Source: BSE
Explanation to the intimation filed on 29th March, 2025 regarding reasoning for the resignation of Chief Financial Officer of the Company.
24 Dec, 2025 | 05:16pm • Source: BSE
Intimation of repeat international order clients amounting to approx 15 Crores.
25 Nov, 2025 | 04:10pm • Source: BSE
Mangalam Drugs And Organics Limited has informed the Exchange about Copy of Newspaper Publication
21 Nov, 2025 | 03:24pm • Source: NSE
Newspaper publication for declaration of Un-Audited Financial results (Standalone and Consolidated) for the quarter ended 30th September, 2025
21 Nov, 2025 | 03:15pm • Source: BSE
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 11, 2025 for...
11 Nov, 2025 | 06:02pm • Source: BSE
Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to...
05 Nov, 2025 | 06:20pm • Source: BSE
Copies of Newspaper Advertisements for Intimation of final hearing at Hon''ble NCLT Hearing and Invitation for Representations- Scheme of merger under Section 230-232 of the...
16 Oct, 2025 | 04:53pm • Source: BSE
Intimation of CTC of Order copy for C.P. (CAA)210(MB)/2025 NCLT hearing dated 23rd September, 2025 on the matter of merger under Section 230 to 232...
15 Oct, 2025 | 03:34pm • Source: BSE
Mangalam Drugs And Organics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
10 Oct, 2025 | 12:09pm • Source:
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 received from MUFG Intime India Private Limited (RTA) for the quarter ended 30th September, 2025.
10 Oct, 2025 | 11:44am • Source: BSE
Submission of Scrutinizer''s Report along with the Voting results for the resolutions passed by the shareholders of the Company at 52nd Annual General Meeting of...
01 Oct, 2025 | 03:28pm • Source: BSE
Appointment of M/s Ragini Chokshi & Co., Secretarial Auditor of the Company for the period of 5 years commencing from 1st April, 2025 to...
30 Sep, 2025 | 06:31pm • Source: BSE
Intimation of Closure of Trading Window from 1st October, 2025 till declaration of Un-audited Financial Results for the Period ending September 30, 2025.
30 Sep, 2025 | 01:20pm • Source: BSE
Summary proceedings of the Annual General meeting of Mangalam Drugs and Organics Limited held on 29th September, 2025 t 3:00 p.m.
29 Sep, 2025 | 06:47pm • Source: BSE
Newspaper publication for Corrigendum to 52nd Annual Report for F.Y.2024-25 in Financial Express in English Language and in Loksatta Vernacular Language.
19 Sep, 2025 | 03:50pm • Source: BSE